Meta-Analysis of Trials of Streptococcal Throat Treatment Programs to Prevent Rheumatic Fever

Pediatric Research

Volumn 28, Issue 7, 2009, Pages

  Lennon, Diana ^a   Kerdemelidis, Melissa ^a   Arroll, Bruce ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN G;

ARTICLE; CLINICAL TRIAL; HUMAN; META ANALYSIS; PRIORITY JOURNAL; RHEUMATIC FEVER; SORE THROAT; STREPTOCOCCAL PHARYNGITIS; SYSTEMATIC REVIEW;

ADOLESCENT; ANIMALS; CHILD; CHILD, PRESCHOOL; COMMUNITY HEALTH SERVICES; FEMALE; HEALTH SERVICES RESEARCH; HUMANS; MALE; PHARYNGITIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RHEUMATIC FEVER; SCHOOL HEALTH SERVICES; STREPTOCOCCAL INFECTIONS;

EID: 67651121736     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181a8e12a     Document Type: Article

References (38)

1. Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet. 2005;366:155-168.
2. Lennon D. Feigin and Cherry Textbook of pediatric infectious diseases. In: Feigin RD, Cherry J, Demmler GJ, et al, eds. Textbook of Pediatric Infectious Diseases. 5th ed. Philadelphia, PA: Saunders; 2004:413-426.
3. Environmental Science and Research Ltd. Notifiable and Other Disease in New Zealand Annual Report 2003. Wellington, New Zealand: Ministry of Health; 2003:1-63.
4. Prevention of rheumatic heart disease. Lancet. 1982;1:143-144.
5. Denny F, Wannamaker L, Brink W, et al. Prevention of rheumatic fever. Treatment of the preceding streptococcal infection. JAMA. 1950;143:151-153.
6. Robertson KA, Volmink JA, Mayosi BM. Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis. BMC Cardiovasc Disord. 2005;5:1-9.
7. Catanzaro F, Rammelkamp C, Chamovitz R. Prevention of rheumatic fever by treatment of streptococcal infections, II. Factors responsible for failures. N Engl J Med. 1958;259:51-57.
8. Rutstein DD, Bauer W, Dorfman A, et al. Jones Criteria (Modified) for guidance in the diagnosis of rheumatic fever: report of the Committee on Standards and Criteria for Programs of Care. Circulation. 1956;13:617-620.
9. Antibiotics and sore throat. Lancet. 1957;272:1128-1130.
10. Gordis L. Effectiveness of comprehensive-care programs in preventing rheumatic fever. N Engl J Med. 1973;289:331-335.
11. Lennon D. Rheumatic fever, a preventable disease? The New Zealand experience in streptococci and streptococcal disease. In: Proceedings of the XIV Lancefield International Symposium on Streptococci and Streptococcal Diseases; 2000; Auckland, New Zealand.
12. Carapetis J, Wolff D, Currie B. Acute rheumatic fever and rheumatic heart disease in the top end of Australia’s Northern Territory. Med J Aust. 1996;164:146-149.
13. Baker M, McNicholas A, Garrett N, et al. Household crowding a major risk factor for epidemic meningococcal disease in Auckland children. Pediatr Infect Dis J. 2000;19:983-990.
14. Hefford M, Crampton P, Foley J. Reducing health disparities through primary care reform: the New Zealand experiment. Health Policy. 2005;72:9-23.
15. Spinetto H. The Auckland Rheumatic Fever Register (1993-1999): an Audit [Master of Health Science, 2002]. Auckland, New Zealand: University of Auckland; 2007.
16. Holmes MC, Rubbo SD. A study of rheumatic fever and streptococcal infection in different social groups in Melbourne. J Hyg (Lond). 1953;51:450-457.
17. Lennon D, Stewart J, Farrell E, et al. A RCT of a school-based primary prevention programme for rheumatic fever. Pediatr Infect Dis J. 2009;28.
18. Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of meta-analyses of randomized controlled trials: the QUOROM statement. Quality of reporting of meta-analyses [comment]. Lancet. 1999;354:1896-1900.
19. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
20. Chun LT, Reddy V, Rhoads GG. Occurrence and prevention of rheumatic fever among ethnic groups of Hawaii. Am J Dis Child. 1984;138:476-478.
21. Coulehan JL, Baacke G, Welty TK, et al. Cost-benefit of a streptococcal surveillance program among Navajo Indians. Public Health Rep. 1982;97:73-77.
22. Phibbs BP. Streptococcal control in school children. Is it worthwhile? Minn Med. 1975;58:607-610.
23. Nordet P, Lopez R, Duenas A, et al. Prevention and control of rheumatic fever and rheumatic heard disease: the Cuban experience (1986-1996-2002). Cardiovasc J Afr. 2008;19:135-140.
24. Atha M, Enos E, Frank C, et al. How an American Indian tribe controlled the Streptococcus. World Health Forum. 1982;3:423-428.
25. Bender TR, Zimmerman RA, Knostman JD, et al. Streptococcal surveillance in remote Arctic populations. The development of a system for detection of group A pharyngitis and the prevention of nonsuppurative sequelae. Acta SocioMed Scand Suppl. 1972;(suppl 6):240-248.
26. Cornfeld D, Hubbard JP. A four-year study of the occurrence of beta-hemolytic Streptococci in 64 school children. N Engl J Med. 1961;264:211-215.
27. Jackson H. Streptococcal control in grade schools. Am J Dis Child. 1976;130:273-279.
28. Nicolle LE, Postl B, Urias B, et al. Outcome following therapy of group A streptococcal infection in schoolchildren in isolated northern communities. Can J Public Health. 1990;81:468-470.
29. Zimmerman RA, Biggs BA, Bolin RA, et al. An effective program for reducing group A streptococcal prevalence. Pediatrics. 1971;48:566-572.
30. Brant LJ, Bender TR, Bross DS. Evaluation of an Alaskan streptococcal control program: importance of the program’s intensity and duration. Prev Med. 1986;15:632-642.
31. Chobin N, Kangos J, Miller J. Strep screening to prevent rheumatic fever: from project to ongoing program. Am J Nurs. 1975;75:1489-1491.
32. Davies AM, Brandt-Auraban A, Szabo M, et al. Primary prevention of rheumatic fever in Jerusalem schoolchildren. Isr J Med Sci. 1968;4:801-808.
33. Davies AM, Halfon ST, Ever-Hadani P, et al. Problems in the primary prevention of rheumatic fever: experience from Jerusalem. Singapore Med J. 1973;14:454-456.
34. Lin S, Kaplan EL, Rao X, et al. A school-based program for control of group A streptococcal upper respiratory tract infections: a controlled trial in Southern China. Pediatr Infect Dis J. 2008;27:753-755.
35. Mooring PK. Primary and secondary rheumatic fever prevention program. Chronicle. 1966;30:55.
36. Gordis L, Lilienfeld A, Rodriguez R. Studies in the epidemiology and preventability of rheumatic fever, II. Socio-economic factors and the incidence of acute attacks. J Chronic Dis. 1969B;21:655-666.
37. Moher D, Pham B, Lawson ML, et al. The inclusion of reports of randomized trials published in languages other than English in systematic reviews. Health Technol Assess. 2003;7:1-6.
38. Lennon D. The decline of acute rheumatic fever (ARF): Unrelated to sore throat management? In: 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy; 2002; San Diego, CA. Abstract G-1481.